Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Linda Cashion"'
Autor:
Gabor M. Rubanyi, Oliver Ast, Cynthia Gross, Husheng Qian, Linda Cashion, Richard N. Harkins, Maxine Bauzon, Alan R. Brooks, Caralee Schaefer, Paul Szymanski, Ann Orme, Harald Petry, Heather Gibson
Publikováno v:
Journal of Interferon & Cytokine Research. 26:699-705
Recombinant interferon-beta (IFN-beta) protein is used successfully for the treatment of multiple sclerosis (MS). Gene therapy might be an alternative approach to overcome drawbacks occurring with IFN-beta protein therapy. A critical issue in develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57dfae4e9c713fdd42ea3469da25d24b
https://doi.org/10.1089/jir.2006.26.699
https://doi.org/10.1089/jir.2006.26.699
Autor:
Cynthia Gross, Richard N. Harkins, Harald Petry, Perry Liu, Linda Cashion, Toni Rose Hidalgo, Hu Sheng Qian, Paul Szymanski, Alan R. Brooks, Claudia Goldman, Caralee Schaefer, Gabor M. Rubanyi, Peiyin Wang
Publikováno v:
Journal of Interferon & Cytokine Research. 26:449-454
Experimental allergic encephalomyelitis (EAE) is a model of central nervous system (CNS) inflammation that follows immunization with certain CNS antigens. The course and clinical manifestations of EAE are similar to those of multiple sclerosis (MS) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0410e3e6a304f7dfed62b8b08cdbf6e5
https://doi.org/10.1089/jir.2006.26.449
https://doi.org/10.1089/jir.2006.26.449
Autor:
Outi Närvänen, Mikko I. Kettunen, Johanna E. Markkanen, Tuomas T. Rissanen, Linda Cashion, Ismo Vajanto, Gabor M. Rubanyi, Pekka Taipale, Seppo Ylä-Herttuala, Katja Arve, Risto A. Kauppinen, Marcin Gruchała, Suvi Jauhiainen, Juha Rutanen
Publikováno v:
The FASEB Journal. 17:100-102
Previous studies have shown that fibroblast growth factor (FGF)-1, FGF-2, and FGF-5 induce therapeutic angiogenesis. Here, we investigated the potential of FGF-4 for therapeutic neovascularization in comparison to vascular endothelial growth factor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e89f5306fb0d02e051e28453495fc92
https://doi.org/10.1096/fj.02-0377fje
https://doi.org/10.1096/fj.02-0377fje
Autor:
Werner Witt, Linda Cashion, Peter Bringmann, Peter Donner, Berthold Baldus, Wolf-Dieter Schleuning
Publikováno v:
Blood. 79:1213-1217
rDSPA alpha 1 (recombinant Desmodus salivary plasminogen activator alpha 1) is a recombinant protein corresponding to a natural plasminogen activator from the vampire bat Desmodus rotundus. The thrombolytic properties of rDSPA alpha 1 and tissue-type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::739316e5ebfa5447ec8128e86a09ed65
https://doi.org/10.1182/blood.v79.5.1213.1213
https://doi.org/10.1182/blood.v79.5.1213.1213
Autor:
Richard N. Harkins, Kelly Plummer, Oliver Ast, Peter Bringmann, Linda Cashion, Andrzej Citkowicz, Claudia Goldmann, Brent R. Larsen, Harald Petry
Publikováno v:
Analytical biochemistry. 376(2)
This study illustrates the application of asymmetrical flow field-flow fractionation (AF4) and light scattering analysis during the development of a gene delivery vehicle based on virus-like particles (VLPs) derived from the human polyoma JC virus. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a6c4051cee310d9e5748cf105f8384
https://pubmed.ncbi.nlm.nih.gov/18342613
https://pubmed.ncbi.nlm.nih.gov/18342613
Autor:
Richard N. Harkins, Susan Harvey, Gabor M. Rubanyi, Andrzej Citkowicz, Brent R. Larsen, Linda Cashion, Mary Rose Masikat, Perry Liu, Harald Petry, Hu Sheng Qian, Oliver Ast, Branka Mitrovic
Publikováno v:
Molecular Therapy. 13:S411-S412
The goal of the present study was to explore the tropism of Virus-Like Particles (VLP) originating from the human polyoma JC- virus (JCV) in vitro and in vivo. VLP have been known for several years to be a promising alternative to the existing viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9006aa29af696468858a44ea119113
https://doi.org/10.1016/j.ymthe.2006.08.1172
https://doi.org/10.1016/j.ymthe.2006.08.1172
Autor:
Kathy White, Linda Cashion, Terry Hermiston, Peiyin Wang, Alan R. Brooks, Richard N. Harkins, Hu Sheng Qian, Ann Orme, Paul Szymanski, R. Jude Samulski, Maxine Bauzon, Cecile Chartier, Perry Liu, Gabor M. Rubanyi, Heather Gibson
Publikováno v:
Molecular Therapy. 11:S370-S371
Interferon-|[szlig]| (IFN-|[szlig]|) is an immunoregulatory cytokine that has been approved as a protein therapeutic for multiple sclerosis (MS). Pharmacokinetic studies have shown that IFN-|[szlig]| has an extremely short half-life in the circulatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9996b5997a570a98ffcf300a3a69d30d
https://doi.org/10.1016/j.ymthe.2005.07.502
https://doi.org/10.1016/j.ymthe.2005.07.502
Autor:
Cynthia Gross, Linda Cashion, Gabor M. Rubanyi, Harald Petry, Hu Sheng Qian, Paul Szymanski, Alan R. Brooks, Claudia Goldman, Heather Gibson, Caralee Schaefer, Peiyin Wang, Toni Rose Arceo, Richard N. Harkins
Publikováno v:
Molecular Therapy. 11:S371
Experimental Allergic Encephalomyelitis (EAE) is a model of central nervous system (CNS) inflammation that ensues following immunization with certain CNS antigens, for example brain derived proteolipid or myelin basic protein. The course and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd0abc4a3562b8a18acda15c5669517
https://doi.org/10.1016/j.ymthe.2005.07.503
https://doi.org/10.1016/j.ymthe.2005.07.503
Autor:
Andrezj Citkowicz, Harald Petry, Gabor M. Rubanyi, Richard N. Harkins, Linda Cashion, Oliver Ast, Brent R. Larsen
Publikováno v:
Molecular Therapy. 11:S68
Virus-like particles (VLP) have been known for several years to be a promising alternative to the existing viral and non-viral DNA delivery systems. VLPs are self-assembled structures composed only of proteins necessary for capsid formation and DNA p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f86d4754695c15078cff06629a1c565
https://doi.org/10.1016/j.ymthe.2005.06.175
https://doi.org/10.1016/j.ymthe.2005.06.175
Autor:
Harald Petry, Hu Sheng Qian, Maxine Bauzon, Peiyin Wang, Jude Samulski, Linda Cashion, Cynthia Gross, Terry Hermiston, Ann Orme, Perry Liu, Gabor M. Rubanyi, Paul Szymanski, Alan R. Brooks, Oliver Ast, Richard N. Harkins
Publikováno v:
Molecular Therapy. 11:S370
Interferon beta (IFN-) has been shown to be an effective drug for patients with multiple sclerosis (MS). However dose-dependent side effects from administration of IFN- protein have limited its therapeutic efficacy and clinical utility. IFN- gene the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::476028b851d3b304f8386ae335e42fad
https://doi.org/10.1016/j.ymthe.2005.07.501
https://doi.org/10.1016/j.ymthe.2005.07.501